Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9970)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 8, 2015 (publication date) through Dec 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu YR, Tang RX, Huang WT, Ren FH, He RQ, Yang LH, Luo DZ, Dang YW, Chen G. Long noncoding RNAs in hepatocellular carcinoma: Novel insights into their mechanism. World J Hepatol 2015; 7(28): 2781-2791 [PMID: 26668690 DOI: 10.4254/wjh.v7.i28.2781] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i28/2781.htm |
| Number | Citing Articles |
| 1 |
Jian-Hua Xu, Wei-Hua Chang, Hang-Wei Fu, Wei-Qun Shu, Tao Yuan, Ping Chen. Upregulated long non-coding RNA LOC90784 promotes cell proliferation and invasion and is associated with poor clinical features in HCC. Biochemical and Biophysical Research Communications 2017; 490(3): 920 doi: 10.1016/j.bbrc.2017.06.141
|
| 2 |
Jiaxin Chen, Shuiping Liu, Xiaotong Hu. Long non-coding RNAs: crucial regulators of gastrointestinal cancer cell proliferation. Cell Death Discovery 2018; 4(1) doi: 10.1038/s41420-018-0051-8
|
| 3 |
Zhangang Xiao, Jing Shen, Lin Zhang, Mingxing Li, Wei Hu, Chihin Cho. Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: Recent progress and future prospects (Review). Oncology Letters 2018; doi: 10.3892/ol.2018.7758
|
| 4 |
Wenkang Shang, Gabriel Komla Adzika, Yujie Li, Qike Huang, Ningding Ding, Bianca Chinembiri, Mohammad Sajjad Ibn Rashid, Jeremiah Ong'achwa Machuki. Molecular mechanisms of circular RNAs, transforming growth factor‐β, and long noncoding RNAs in hepatocellular carcinoma. Cancer Medicine 2019; 8(15): 6684 doi: 10.1002/cam4.2553
|
| 5 |
Jie Bao, Xiaoqi Chen, Yuge Hou, Gailing Kang, Qiaoli Li, Yun Xu. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway. Biomedicine & Pharmacotherapy 2018; 107: 824 doi: 10.1016/j.biopha.2018.08.079
|
| 6 |
Libai Lu, Shubo Li, Ying Zhang, Zongjiang Luo, Yichen Chen, Jiasheng Ma, Pengyu Chen, Wei Wang, Jian Pu, Jianchu Wang. GFI1-Mediated Upregulation of LINC00675 as a ceRNA Restrains Hepatocellular Carcinoma Metastasis by Sponging miR-942-5p. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.607593
|
| 7 |
Galina Khemlina, Sadakatsu Ikeda, Razelle Kurzrock. The biology of Hepatocellular carcinoma: implications for genomic and immune therapies. Molecular Cancer 2017; 16(1) doi: 10.1186/s12943-017-0712-x
|
| 8 |
Aiping Yu, Ying Wang, Jianhai Yin, Jing Zhang, Shengkui Cao, Jianping Cao, Yujuan Shen. Microarray analysis of long non-coding RNA expression profiles in monocytic myeloid-derived suppressor cells in Echinococcus granulosus-infected mice. Parasites & Vectors 2018; 11(1) doi: 10.1186/s13071-018-2905-6
|
| 9 |
Matteo Canale, Paola Ulivi, Francesco Giuseppe Foschi, Emanuela Scarpi, Serena De Matteis, Gabriele Donati, Giorgio Ercolani, Mario Scartozzi, Luca Faloppi, Alessandro Passardi, Emiliano Tamburini, Martina Valgiusti, Giorgia Marisi, Giovanni Luca Frassineti, Andrea Casadei Gardini. Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma. Critical Reviews in Oncology/Hematology 2018; 129: 44 doi: 10.1016/j.critrevonc.2018.06.017
|
| 10 |
Yingchao Wang, Wei Jing, Weijie Ma, Chunzi Liang, Hongyan Chai, Jiancheng Tu. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma. Cancer Biomarkers 2018; 22(2): 227 doi: 10.3233/CBM-170781
|
| 11 |
Heqiang Qi, Yuyan Lu, Jie Lv, Huita Wu, Jing Lu, Changmao Zhang, Sheng Zhang, Qing Bao, Xiuming Zhang, Chengrong Xie, Zhenyu Yin. The long noncoding RNA lncPARP1 contributes to progression of hepatocellular carcinoma through up-regulation of PARP1. Bioscience Reports 2018; 38(3) doi: 10.1042/BSR20180703
|
| 12 |
Yan Zhou, Ping He, Xuhua Xie, Changyu Sun. Knockdown of SUMO1P3 represses tumor growth and invasion and enhances radiosensitivity in hepatocellular carcinoma. Molecular and Cellular Biochemistry 2019; 450(1-2): 125 doi: 10.1007/s11010-018-3379-8
|
| 13 |
Meenakshi Gupta, Kumari Chandan, Maryam Sarwat. Role of microRNA and Long Non-Coding RNA in Hepatocellular Carcinoma. Current Pharmaceutical Design 2020; 26(4): 415 doi: 10.2174/1381612826666200115093835
|
| 14 |
Lee Jin Lim, Samuel Y.S. Wong, Feiyang Huang, Sheng Lim, Samuel S. Chong, London Lucien Ooi, Oi Lian Kon, Caroline G. Lee. Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma. Cancer Research 2019; 79(20): 5131 doi: 10.1158/0008-5472.CAN-19-0255
|
| 15 |
Johanna K. DiStefano. Disease Gene Identification. Methods in Molecular Biology 2018; 1706: 91 doi: 10.1007/978-1-4939-7471-9_6
|
| 16 |
Dan Li, Xianbin Tang, Man Li, Yi Zheng. Long noncoding RNA DLX6‐AS1 promotes liver cancer by increasing the expression of WEE1 via targeting miR‐424‐5p. Journal of Cellular Biochemistry 2019; 120(8): 12290 doi: 10.1002/jcb.28493
|
| 17 |
Ting-Ting Ji, Xuan Huang, Jie Jin, Sheng-Hua Pan, Xiao-Ju Zhuge. Inhibition of long non-coding RNA TUG1 on gastric cancer cell transference and invasion through regulating and controlling the expression of miR-144/c-Met axis. Asian Pacific Journal of Tropical Medicine 2016; 9(5): 508 doi: 10.1016/j.apjtm.2016.03.026
|
| 18 |
Wen Ni, Yuqin Zhang, Zetao Zhan, Feng Ye, Yonghao Liang, Jing Huang, Keli Chen, Longhua Chen, Yi Ding. A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1. Journal of Hematology & Oncology 2017; 10(1) doi: 10.1186/s13045-017-0449-4
|
| 19 |
Guannan Wang, Xiaosan Fang, Meng Han, Xiaoming Wang, Qiang Huang. MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3358
|
| 20 |
Yan Yang, Caiyu Jiang, Yang Yang, Lu Guo, Jiang Huang, Xingren Liu, Chi Wu, Jun Zou. Silencing of LncRNA-HOTAIR decreases drug resistance of Non-Small Cell Lung Cancer cells by inactivating autophagy via suppressing the phosphorylation of ULK1. Biochemical and Biophysical Research Communications 2018; 497(4): 1003 doi: 10.1016/j.bbrc.2018.02.141
|
| 21 |
Reza Arefnezhad, Sara Ashna, Fatemeh Rezaei‐Tazangi, Seyed Mahdi Arfazadeh, Seyede Shabnam Seyedsalehie, Shaghayegh Yeganeafrouz, Melika Aghaei, Mandana Sanandaji, Ramin Davoodi, Sareh Ranjbar Karim Abadi, Massoud Vosough. Noncoding RNAs and programmed cell death in hepatocellular carcinoma: Significant role of epigenetic modifications in prognosis, chemoresistance, and tumor recurrence rate. Cell Biology International 2024; 48(5): 556 doi: 10.1002/cbin.12145
|
| 22 |
Li-Xiang Zhang, Pan-Quan Luo, Zhi-Jian Wei, A-Man Xu, Tao Guo. Expression and significant roles of the long non-coding RNA CASC19/miR-491-5p/HMGA2 axis in the development of gastric cancer. World Journal of Gastrointestinal Oncology 2024; 16(8): 3559-3584 doi: 10.4251/wjgo.v16.i8.3559
Abstract(185) |
Core Tip(156) |
Full Article(HTML)(879)
|
Full Article with Cover (PDF)-31879K(67)
|
Audio-1006K(3)
|
Peer-Review Report-217K(18)
|
Answering Reviewers-137K(19)
|
Supplementary Material-33K(18)
|
Full Article (PDF)-31647K(41)
|
Full Article (XML)-158K(27)
|
Times Cited (0)
|
Total Visits (2111)
|
Open
|
| 23 |
Deyuan Zhang, Jinyu Cao, Qingling Zhong, Liangtao Zeng, Chang Cai, Lang Lei, Wen Zhang, Fanrong Liu. Long noncoding RNA PCAT-1 promotes invasion and metastasis via the miR-129-5p-HMGB1 signaling pathway in hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2017; 95: 1187 doi: 10.1016/j.biopha.2017.09.045
|
| 24 |
Nandi Li, Yingchao Wang, Xuefang Liu, Ping Luo, Wei Jing, Man Zhu, Jiancheng Tu. Identification of Circulating Long Noncoding RNA HOTAIR as a Novel Biomarker for Diagnosis and Monitoring of Non–Small Cell Lung Cancer. Technology in Cancer Research & Treatment 2017; 16(6): 1060 doi: 10.1177/1533034617723754
|
| 25 |
Zhixiang Li, Jun Qian, Jing Li, Chao Zhu. Knockdown of lncRNA‑HOTAIR downregulates the drug‑resistance of breast cancer cells to doxorubicin via the PI3K/AKT/mTOR signaling pathway. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7629
|
| 26 |
Natalia Salinas Parra, Heather M. Ross, Adnan Khan, Marisa Wu, Risa Goldberg, Lokesh Shah, Sarah Mukhtar, Jacob Beiriger, Alexis Gerber, Dina Halegoua-DeMarzio. Advancements in the Diagnosis of Hepatocellular Carcinoma. International Journal of Translational Medicine 2023; 3(1): 51 doi: 10.3390/ijtm3010005
|
| 27 |
Yarui Li, Mudan Ren, Yan Zhao, Xinlan Lu, Mengyao Wang, Junbi Hu, Guifang Lu, Shuixiang He. MicroRNA-26a inhibits proliferation and metastasis of human hepatocellular carcinoma by regulating DNMT3B-MEG3 axis. Oncology Reports 2017; 37(6): 3527 doi: 10.3892/or.2017.5579
|
| 28 |
Xiaoqing Yu, Jingsong Zhang, Rui Yang, Chun Li, Zhenguo Zhang. Identification of Long Noncoding RNA Biomarkers for Hepatocellular Carcinoma Using Single-Sample Networks. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/8579651
|
| 29 |
Yong Qin, Chao‐Jun Wang, Hai‐Lin Ye, Guan‐Xiong Ye, Shi Wang, De‐Biao Pan, Jun Wang, He‐Juan Shen, Sheng‐Qian Xu. WWP2 overexpression inhibits the antitumor effects of doxorubicin in hepatocellular carcinoma. Cell Biology International 2022; 46(10): 1682 doi: 10.1002/cbin.11856
|
| 30 |
Patrick Reichl, Wolfgang Mikulits. Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review). Oncology Reports 2016; 36(2): 613 doi: 10.3892/or.2016.4842
|
| 31 |
Haojun Xiong, Bo Li, Jintao He, Yijun Zeng, Yan Zhang, Fengtian He. lncRNA HULC promotes the growth of hepatocellular carcinoma cells via stabilizing COX-2 protein. Biochemical and Biophysical Research Communications 2017; 490(3): 693 doi: 10.1016/j.bbrc.2017.06.103
|
| 32 |
Mona Sadeghalvad, Kamran Mansouri, Hamid-Reza Mohammadi-Motlagh, Farshid Noorbakhsh, Ali Mostafaie, Sadaf Alipour, Nima Rezaei. Long non-coding RNA HOTAIR induces the PI3K/AKT/mTOR signaling pathway in breast cancer cells. Revista da Associação Médica Brasileira 2022; 68(4): 456 doi: 10.1590/1806-9282.20210966
|
| 33 |
Qiqin Song, Hongyue Zhang, Jinan He, Hongyan Kong, Ran Tao, Yu Huang, Haijing Yu, Zhongwei Zhang, Zhiyong Huang, Lai Wei, Chenghai Liu, Likui Wang, Qin Ning, Jiaquan Huang. Long non-coding RNA LINC00473 acts as a microRNA-29a-3p sponge to promote hepatocellular carcinoma development by activating Robo1-dependent PI3K/AKT/mTOR signaling pathway. Therapeutic Advances in Medical Oncology 2020; 12 doi: 10.1177/1758835920937890
|
| 34 |
Nuobei Zhang, Hao Shen, Shenan Huang, Fenfen Wang, Huifang Liu, Fen Xie, Lei Jiang, Xin Chen. LncRNA FGD5-AS1 functions as an oncogene to upregulate GTPBP4 expression by sponging miR-873-5p in hepatocellular carcinoma . European Journal of Histochemistry 2021; 65(4) doi: 10.4081/ejh.2021.3300
|
| 35 |
Hongyong Zhang, Yufeng Wang, Zhikui Liu, Bowen Yao, Changwei Dou, Meng Xu, Qing Li, Yuli Jia, Shengli Wu, Kangsheng Tu, Qingguang Liu. Retracted: Lymphocyte‐specific protein 1 inhibits the growth of hepatocellular carcinoma by suppressing ERK1/2 phosphorylation. FEBS Open Bio 2016; 6(12): 1227 doi: 10.1002/2211-5463.12139
|
| 36 |
Wei Jing, Xiaogai Li, Ruoyu Peng, Shaogang Lv, Yan Zhang, Zheng Cao, Jiancheng Tu, Liang Ming. The diagnostic and prognostic significance of long noncoding RNAs expression in thyroid cancer: A systematic review and meta-analysis. Pathology - Research and Practice 2018; 214(3): 327 doi: 10.1016/j.prp.2018.01.008
|
| 37 |
Jiangfeng Hu, Chenlin Song, Bensong Duan, Xiaoyan Zhang, Dongliang Li, Liang Zhu, Hengjun Gao. LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma. Oncotarget 2017; 8(58): 97835 doi: 10.18632/oncotarget.18279
|
| 38 |
Fizzah Abid, Talha Iqbal, Khushbukhat Khan, Yasmin Badshah, Janeen H Trembley, Naeem Mahmood Ashraf, Maria Shabbir, Tayyaba Afsar, Ali Almajwal, Suhail Razak. Analyzing PKC Gamma (+ 19,506 A/G) polymorphism as a promising genetic marker for HCV-induced hepatocellular carcinoma. Biomarker Research 2022; 10(1) doi: 10.1186/s40364-022-00437-6
|